4//SEC Filing
Telling Fred 4
Accession 0001382225-25-000002
CIK 0001174940other
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 15, 4:38 PM ET
Size
7.7 KB
Accession
0001382225-25-000002
Insider Transaction Report
Form 4
ORAGENICS INCOGEN
Telling Fred
Director
Transactions
- Sale
Common Stock
2025-12-12$0.94/sh−210$198→ 34,538 total - Award
Non-Employee Director Option (Right to Buy)
2025-12-11+125,000→ 125,000 totalExercise: $0.93From: 2025-12-11Exp: 2035-12-11→ Common Stock (125,000 underlying)
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $0.9440 to $0.9451. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F2]Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.
Documents
Issuer
ORAGENICS INC
CIK 0001174940
Entity typeother
Related Parties
1- filerCIK 0001382225
Filing Metadata
- Form type
- 4
- Filed
- Dec 14, 7:00 PM ET
- Accepted
- Dec 15, 4:38 PM ET
- Size
- 7.7 KB